Diagnosis and Management of Myeloid Malignancies
22nd October 2018
Education Centre (Dept. 17), The Christie, Manchester, M20 4BX
Overview
This study day is designed to increase knowledge on the diagnosis and management of Myeloid Malignancies.
Myeloid disease groups, their treatments, novel therapies, ethics and consent, geriatric hematology and living with myeloid malignancies will be covered by the day.
Intended Audience
This is aimed at staff working in haematology either inpatient or outpatient settings. Also open to nurses, and other allied health professionals.
Learning outcomes
To provide a good knowledge base of the haematological malignancies and the complications and challenges that can occur when caring for them.
Topics covered
- Myeloproliferative Disorder (MPD)
- Chronic Myeloid Leukaemia (CML)
- Acute Myeloid Leukaemia
- Ethics and consent
- Geriatric Haematology
- Living with Myeloid Malignancies
Aim/objectives
The day is designed to increase knowledge on the Diagnosis and management of Myeloid Malignancies.
Key Themes
Discussion and understanding of main myeloid disease groups, their treatments, novel therapies, ethics and consent, geriatric haematology and living with myeloid malignancies
This course has been prepared by and will be delivered by the experts at the Christie School of Oncology
Quick Information
Places are currently available. | |
---|---|
Date | 22nd October 2018 |
Venue Google Maps |
Education Centre (Dept. 17), The Christie, Manchester, M20 4BX |
Course Fee | £60.00 General Admission |
Closing Date | Places will be offered on a first-come-first-served basis and therefore we are unable to provide a precise closing date. |
No of Places | Unlimited |
Dress code | Professional/Semi-formal |